Last updated: June 20, 2026
CHG SCRUB Suppliers: Who Makes Chlorhexidine Gluconate Skin Prep and What to Source
Executive summary: CHG SCRUB is a chlorhexidine gluconate (CHG) skin cleansing product used for pre-procedural antisepsis and wound/skin preparation workflows. Supply is typically handled through (1) brand-manufacturer programs tied to FDA-registered drug establishments, (2) contract manufacturing and packaged-goods channels for CHG topical solutions and impregnated applicators, and (3) wholesale distributors and group purchasing organizations (GPOs). Without the specific CHG SCRUB label strength, dosage form (wash/solution, wipe, foam, impregnated cloth, swab, or scrub brush), and pack size, supplier lists can’t be stated accurately.
What suppliers provide CHG SCRUB (chlorhexidine gluconate) skin scrub products?
Answer (short): Suppliers fall into three lanes: brand manufacturers, contract manufacturers/packagers, and authorized wholesale distributors of FDA-approved CHG topical antiseptic products.
Brand-manufactured CHG skin prep: what to look for
- Product name and label claim: “chlorhexidine gluconate” antiseptic skin preparation
- Strength and vehicle (aqueous solution vs alcohol-based vs detergent/gel base)
- Dosage form (scrub wash, wipe, impregnated cloth, swab)
- Indications (surgical site preparation vs other antiseptic uses)
Contract manufacturing and secondary packaging
Many CHG topical SKUs are produced under contract and then packaged under:
- hospital private label
- distributor house brands
- retail “scrub” SKUs
Key sourcing checks:
- FDA drug establishment registration for the manufacturer/packager
- Quality system scope (sterile vs nonsterile; aseptic or not)
- Lot-level traceability and COA availability
- Compatibility of CHG with applicator materials (for wipes/swabs)
Distribution channels
- Wholesale distributors: deliver through standard pharma wholesaler networks
- GPO contracting: ties to hospital formularies, compliance lists, and SKU standardization
- JIT and consignment: used in high-utilization perioperative settings
Which contract manufacturers can supply chlorhexidine gluconate scrub formats?
Answer (short): Contract suppliers for CHG scrubs typically support nonsterile topical solutions and wipes and handle formulation, filling, and packaging, with downstream labeling under customer or distributor brands.
Common manufacturing scope for CHG scrub SKUs
- Aqueous CHG topical solutions (wash/scrub)
- CHG impregnated wipes or cloths
- CHG swabs with standardized absorbent media
- Nonsterile filling into bottles/tubs/sachets
Capability gate checks
- Extractables/leachables controls for applicators
- CHG assay and stability program for labeled shelf life
- Cleaning validation for CHG residual carryover in shared lines
- Packaging closure integrity studies
- Microbial limits testing plan for topical products
How do distributors and GPOs affect CHG SCRUB supplier availability?
Answer (short): Hospital purchasing often consolidates CHG scrub SKUs through GPO agreements and distributor contracts, which changes who is “available” in practice even when multiple manufacturers exist in the market.
What changes the supplier outcome
- GPO contract award to a specific labeled SKU and pack size
- Substitution rules for therapeutically equivalent antiseptics
- Hospital formulary standardization to fewer SKUs
- Allocation policies during supply constraints
Procurement artifacts
- Contract item numbers (CIs) linked to a specific NDC
- Contract terms specifying manufacturer-of-record or labeler
- Volume commitments and replenishment SLAs
What FDA-linked identifiers determine the true supplier for CHG SCRUB?
Answer (short): The “supplier” is tied to FDA establishment registration and labeler/NDC chain, not the generic ingredient name alone.
Identifiers to lock
- NDC for the exact CHG SCRUB SKU (label strength and dosage form)
- Labeler on the NDC record (this is often not the manufacturer)
- FDA establishment registration for the manufacturing and packager sites
- Lot numbering and COA issuer on incoming materials
Regulatory classification
CHG scrub products are typically marketed as antiseptic topical drug products. The relevant FDA frameworks apply to:
- drug manufacturing controls (nonsterile)
- labeling and indication statements
- stability, testing, and adverse event reporting
What patents or exclusivity constrain CHG SCRUB supply?
Answer (short): CHG is an established active ingredient, so the market is usually driven by formulation and packaging differentiation rather than broad active ingredient exclusivity. Supply constraints usually come from manufacturing capacity and regulatory/quality line clearance, not patent exclusivity.
Where IP can still matter in practice
- Proprietary dosage form technologies (specific applicator types)
- Stabilized formulations (vehicle systems, surfactant blends)
- Manufacturing process controls and validated parameters
- Trademarked packaging and hospital protocol bundles
How many suppliers exist for chlorhexidine gluconate skin prep products?
Answer (short): The number of suppliers is high across the broader CHG topical antiseptic space (solution, wipes, swabs), but the count for the specific product “CHG SCRUB” depends on its exact:
- dosage form (wash vs wipe vs swab)
- labeled strength
- pack size
- labeler/brand
What generic entry risks exist for CHG SCRUB?
Answer (short): “Generic entry risk” is usually low for CHG itself, but it can show up as:
- shortages due to limited contract capacity
- substitution-driven switching in hospitals
- quality holds tied to manufacturing deviations at a few key sites
Which manufacturing/IP barriers block substitute CHG SCRUB products?
Answer (short): Barriers are usually operational and compliance related:
- line clearance and validated cleaning for CHG
- applicator material compatibility
- shelf-life and stability for the labeled vehicle system
- documentation readiness for regulatory inspections
Key Takeaways
- CHG SCRUB supply is determined by the exact NDC and dosage form, not only the ingredient name.
- Supplier landscapes split into brand manufacturers, contract manufacturers/packagers, and authorized distributors/GPO channels.
- Practical “supplier availability” is driven by hospital contract SKU constraints and manufacturing capacity, not CHG active ingredient exclusivity.
FAQs
-
How do I identify the manufacturer behind a specific CHG scrub NDC?
Use the NDC labeler and cross-walk to FDA drug establishment registration for the listed manufacturing and packager sites.
-
Are CHG wipes/swabs supplied by the same manufacturers as CHG wash solutions?
Often they are shared at the contract level, but applicator manufacturing, impregnation, and packaging introduce different capability requirements.
-
What packaging differences change supplier qualification for CHG scrub?
Bottle/tub vs single-use sachet vs wipe/cloth vs swab changes container closure integrity, stability program design, and QA release testing.
-
Why do CHG scrub products sometimes experience short supply even when CHG is generic?
Limits can come from specific line capacity for the labeled vehicle, applicator impregnation capability, or regulatory quality holds at a few high-throughput sites.
-
Can distributors re-label CHG scrub products under private label?
Yes. Private label and distributor house brands can shift the “supplier-of-record” while keeping the same underlying manufacturer chain, which is why NDC and establishment registration matter.
References (APA)
- FDA. Drug Establishments (Registration and Listing). U.S. Food and Drug Administration.
- FDA. NDC Directory. U.S. Food and Drug Administration.
- FDA. Orange Book (Hatch-Waxman) database. U.S. Food and Drug Administration.
(No additional supplier list can be produced accurately without the exact CHG SCRUB NDC/dosage form/strength, which determines the specific labeler and manufacturing chain.)
